Copay Assistance – Good For Patients, Bad For Prices

Byadmin

Annals of Internal MedicinePeter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
 
 

Similar Posts

Employers Are Doing a Terrible Job of Covering the Cost of Pregnancy

Employers Are Doing a Terrible Job of Covering the Cost of Pregnancy

Byadmin

If you get insurance through your employer, you don’t have to worry about whether insurance will cover maternity care. The company is required to do so by law. But that doesn’t mean the insurer will be very generous. Because in the United States, having coverage doesn’t mean you’re well-covered. Employers are increasingly corralling their employees into high…

Rural Voters Elected President Trump. Is He about to Ruin Their Local Hospitals?

Byadmin

It’s not an easy time to be a small, rural hospital. Insurance companies aren’t willing to pay generously for your services, given your measly market share. You are increasingly forced to compete against large integrated healthcare systems – conglomerations of urban, suburban and rural providers armed with big marketing budgets and specialized (generously reimbursed!) services….

Think Fast and You'll Lose Money Quickly (A Behavioral Economics Explanation of Irrational Gambling)

Byadmin

Shutterstock I have just given you $78. (I’m a generous guy.) Now I’m giving you a choice: you can enter a lottery where you have a 75% chance of losing that $78 and a 25% of keeping it, or you can hold on to $20 and avoid the lottery all together. Quick—tell me what you…

Should Presidential Candidates Be Vilifying Physicians For The High Cost Of Medical Care?

Byadmin

When asked what enemies she was proud to have made during her political career, Hillary Clinton mentioned, in order, “the NRA, the health insurance companies, the drug companies [and] the Iranians.” Pretty villainous company to place healthcare industries into. But Clinton is not alone among presidential candidates in vilifying pharmaceutical and insurance industries for, as…

| |

If Costs Are Unknown, Can Doctors Still Talk About Them?

Byadmin

I have been writing a bit lately on the need for healthcare providers to talk with their patients about healthcare costs, if for no other reason than to enable patients to determine whether they can afford to pay for the healthcare that their doctors are recommending them to receive.  I have been criticized for this position, on…

The Cost of New Cancer Drugs (In One Picture)

Byadmin

“Specialty drugs” – that’s what they’re called. Not the pills of old, these pharmaceuticals are often given intravenously or through injection. Often more biologic in their synthesis than chemical, they are expensive to produce and often target narrow disease processes, meaning the number of patients likely to benefit from them is much much smaller than,…

Leave a Reply